J Aleksova1,2,3, S Kurniawan4, G J Elder5,6. 1. Hudson Institute of Medical Research, Clayton, VIC, 3168, Australia. 2. Department of Medicine, Monash University, Clayton, VIC, 3168, Australia. 3. Department of Endocrinology, Monash Health, Clayton, VIC, 3168, Australia. 4. School of Medicine, The University of Notre Dame Australia, Darlinghurst, NSW, 2010, Australia. 5. Department of Renal Medicine, Westmead Hospital, Westmead, NSW, 2145, Australia. g.elder@garvan.org.au. 6. Osteoporosis and Bone Biology Division, Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia. g.elder@garvan.org.au.
Abstract
Fracture risk increases in end-stage kidney disease (ESKD), but bone mineral density (BMD) measurement is less predictive of risk than in the general population. In this study of patients with ESKD, a lower trabecular bone score (TBS), indicative of microarchitectural deterioration, was associated with higher bone turnover markers and prevalent non-vertebral fracture. INTRODUCTION: Declining renal function carries increased fracture risks, but BMD is less predictive of fracture for dialysis patients than the general population. The TBS, obtained from lumbar spine dual-energy X-ray absorptiometry (DXA) images, provides information on microarchitectural integrity not captured by BMD. The aim of this study was to assess associations of the TBS to clinical, DXA, radiological, and laboratory measures in patients with ESKD undergoing kidney and simultaneous pancreas kidney (SPK) transplantation. METHODS: A total of 147 patients with ESKD underwent pre-transplant laboratory testing, DXA, lateral spine X-ray, and structured history within 4 weeks of transplantation. Associations of the TBS to demographic data, prevalent fracture, BMD, and laboratory variables were assessed. RESULTS: Of 147 patients (60% male, mean age 48 ± 13 years), 36% had diabetes mellitus (DM) and 54 patients had fractures: 21 prevalent vertebral fractures only, 22 non-vertebral fractures only, and 11 had both. The mean TBS (1.345 ± 0.125) was lower in patients undergoing SPK than kidney-only transplants (1.292 vs. 1.364, p = 0.001). The TBS correlated to spine and total hip BMD, body mass index and inversely to parathyroid hormone, alkaline phosphatase and procollagen 1 N-propeptide. By multivariable logistic regression, lower TBS was significantly associated to prior non-vertebral fracture (p = 0.026). CONCLUSIONS: A lower TBS, suggestive of increased microarchitectural damage, was associated with type 1 DM, markers of higher bone turnover, and prevalent fracture. These data support the need for prospective studies to evaluate whether TBS inclusion improves fracture prediction in patients with ESKD.
Fracture risk increases in end-stage kidney disease (ESKD), but bone mineral density (BMD) measurement is less predictive of risk than in the general population. In this study of patients with ESKD, a lower trabecular bone score (TBS), indicative of microarchitectural deterioration, was associated with higher bone turnover markers and prevalent non-vertebral fracture. INTRODUCTION: Declining renal function carries increased fracture risks, but BMD is less predictive of fracture for dialysis patients than the general population. The TBS, obtained from lumbar spine dual-energy X-ray absorptiometry (DXA) images, provides information on microarchitectural integrity not captured by BMD. The aim of this study was to assess associations of the TBS to clinical, DXA, radiological, and laboratory measures in patients with ESKD undergoing kidney and simultaneous pancreas kidney (SPK) transplantation. METHODS: A total of 147 patients with ESKD underwent pre-transplant laboratory testing, DXA, lateral spine X-ray, and structured history within 4 weeks of transplantation. Associations of the TBS to demographic data, prevalent fracture, BMD, and laboratory variables were assessed. RESULTS: Of 147 patients (60% male, mean age 48 ± 13 years), 36% had diabetes mellitus (DM) and 54 patients had fractures: 21 prevalent vertebral fractures only, 22 non-vertebral fractures only, and 11 had both. The mean TBS (1.345 ± 0.125) was lower in patients undergoing SPK than kidney-only transplants (1.292 vs. 1.364, p = 0.001). The TBS correlated to spine and total hip BMD, body mass index and inversely to parathyroid hormone, alkaline phosphatase and procollagen 1 N-propeptide. By multivariable logistic regression, lower TBS was significantly associated to prior non-vertebral fracture (p = 0.026). CONCLUSIONS: A lower TBS, suggestive of increased microarchitectural damage, was associated with type 1 DM, markers of higher bone turnover, and prevalent fracture. These data support the need for prospective studies to evaluate whether TBS inclusion improves fracture prediction in patients with ESKD.
Entities:
Keywords:
Bone turnover; End-stage kidney disease; Fracture; Trabecular bone score
Authors: Kristine E Ensrud; Li-Ying Lui; Brent C Taylor; Areef Ishani; Michael G Shlipak; Katie L Stone; Jane A Cauley; Sophie A Jamal; Diana M Antoniucci; Steven R Cummings Journal: Arch Intern Med Date: 2007-01-22
Authors: T Neumann; S Lodes; B Kästner; T Lehmann; D Hans; O Lamy; U A Müller; G Wolf; A Sämann Journal: Osteoporos Int Date: 2015-07-18 Impact factor: 4.507
Authors: A M Alem; D J Sherrard; D L Gillen; N S Weiss; S A Beresford; S R Heckbert; C Wong; C Stehman-Breen Journal: Kidney Int Date: 2000-07 Impact factor: 10.612
Authors: Ludmila Brunerová; Petra Ronová; Jana Verešová; Petra Beranová; Jana Potoèková; Petr Kasalický; Ivan Rychlík Journal: Kidney Blood Press Res Date: 2016-06-23 Impact factor: 2.687
Authors: N C Harvey; C C Glüer; N Binkley; E V McCloskey; M-L Brandi; C Cooper; D Kendler; O Lamy; A Laslop; B M Camargos; J-Y Reginster; R Rizzoli; J A Kanis Journal: Bone Date: 2015-05-16 Impact factor: 4.398
Authors: Ludmila Brunerová; Petr Kasalický; Jana Verešová; Renata Lažanská; Jana Potočková; Ivan Rychlík Journal: Int Urol Nephrol Date: 2020-02-03 Impact factor: 2.370
Authors: Mary P Kotlarczyk; Subashan Perera; Neil M Resnick; David A Nace; Susan L Greenspan Journal: Arch Osteoporos Date: 2020-05-26 Impact factor: 2.617
Authors: Z Kužmová; M Kužma; A Gažová; M Kovářová; P Jackuliak; Z Killinger; J Kyselovič; J Payer Journal: Physiol Res Date: 2021-11-30 Impact factor: 1.881
Authors: M Abdalbary; M Sobh; S Elnagar; M A Elhadedy; N Elshabrawy; M Abdelsalam; K Asadipooya; A Sabry; A Halawa; A El-Husseini Journal: Osteoporos Int Date: 2022-06-24 Impact factor: 5.071
Authors: P Evenepoel; J Cunningham; S Ferrari; M Haarhaus; M K Javaid; M-H Lafage-Proust; D Prieto-Alhambra; P U Torres; J Cannata-Andia Journal: Osteoporos Int Date: 2021-06-15 Impact factor: 4.507